HomeEWTX • NASDAQ
add
Edgewise Therapeutics Inc
Previous close
$11.42
Day range
$11.50 - $12.51
Year range
$10.60 - $38.12
Market cap
1.29B USD
Avg Volume
2.52M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 45.54M | 34.49% |
Net income | -39.66M | -31.58% |
Net profit margin | — | — |
Earnings per share | -0.42 | 10.64% |
EBITDA | -44.96M | -34.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 470.17M | 47.67% |
Total assets | 486.82M | 43.17% |
Total liabilities | 27.60M | 30.16% |
Total equity | 459.22M | — |
Shares outstanding | 95.21M | — |
Price to book | 2.36 | — |
Return on assets | -22.81% | — |
Return on capital | -23.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -39.66M | -31.58% |
Cash from operations | -26.96M | -0.47% |
Cash from investing | 20.92M | -22.46% |
Cash from financing | 2.90M | -94.54% |
Net change in cash | -3.14M | -105.91% |
Free cash flow | -13.88M | 11.19% |
About
Founded
2017
Headquarters
Website
Employees
110
